A Biopsy is performed to obtain a piece of tissue or a sample of cells from a patient’s body. Biopsy devices such as Biopsy Needles, biopsy needles, forceps, biopsy guidance system, and others are used for the same. The Global Biopsy Devices Market is anticipated to scale to a valuation of USD 2.4 Bn at a CAGR of 6.4% by the end of the forecast period of 2016-2022, as per a recent study by Market Research Future (MRFR).
A biopsy is carried out to diagnose any inflammatory conditions, infestations diseases, in case of organ transplantation, and for the evaluation of fertility. However, biopsy has gained traction in the cancer arena. A biopsy is the only definitive way to determine the presence of cancer. Oncology diseases are spreading at an alarming rate which has generated massive demand for screening. There is a huge demand for high-quality diagnostic processes, especially huge unmet needs in the emerging economies of the world create a conducive environment for the growth of the global biopsy devices market.
Global Biopsy Devices Market – Competitive Landscape
The notable players in the Global Biopsy Devices Market include Focal Therapeutics, Inc., C. R. Bard, Inc. Creganna, Scion Medical Technologies, LLC. (UK), BD, Integra LifeSciences Corporation, Hologic, Inc., Argon Medical Devices, Inc., Precision Biopsy, LLC, Cook Medical, and Leica Biosystems.
Get Free Sample Report @ https://www.marketresearchfuture.com/sample_request/2250
Industry Updates
- August 2018- AngioDynamics, Inc., a leader in minimally invasive medical devices, announced the acquisition of a biopsy sealant technology from Surgical Specialties, LLC, a medical device company headquartered in Massachusetts. The BioSentry Tract Sealant System (BioSentry) technology delivers a hydrogel plug designed to alleviate the risk of collapsed lung after having undergone a biopsy.
- September 2018- Cancer diagnostics firm Foundation Medicine introduced its new liquid biopsy test called FoundationOne Liquid which can be used for solid tumors. The device is designed to detect substitutions, copy number alterations (CNAs), insertion and deletion alterations (indels), and select gene rearrangements.
Global Biopsy Devices Market – Segmentation
The Global Biopsy Devices Market has been segmented based on product type, application, and end user.
By product type, the global biopsy devices market has been segmented into biopsy guns, biopsy guidance system, biopsy needles, forceps, and others.
By application, the global biopsy devices market has been segmented into bone marrow biopsy, surgical biopsy, skin biopsy, needle biopsy, Cancer Diagnosis, and others.
By end user, the global biopsy devices market has been segmented into hospitals, specialty clinics, diagnostic centers, academic & research institutes, and others.
Global Biopsy Devices Market – Regional Analysis
By region, the global biopsy devices market has been segmented into the Americas, Asia Pacific (APAC), Europe, and the Middle East & Africa (MEA).
The Americas account for the most significant share of the global biopsy devices market. High prevalence of oncology diseases generate high demand for cancer screening and consequently drive the market for biopsy devices. High healthcare expenditure, the existence of key players in the region and extensive use of technologically advanced biopsy devices in the region support the growth of the market. North America is leading the Americas market and is anticipated to reach USD 2.4 Bn by the end of 2022.
Europe is the second largest market for biopsy devices. High healthcare expenditure and high expenditure on healthcare infrastructure boost the growth of the market.
APAC is on its path to emerge as the fastest growing market for biopsy devices. Surging prevalence of cancer, growing awareness which has led to increased demand for cancer screening, and expansion of healthcare budget in emerging economies are factors substantiating the growth of the APAC market. In addition, the governments in the region are endeavoring towards raising awareness and encouraging individuals to undertake cancer screening which is acting as a growth influencer.
Browse Complete 80 Pages Premium Research Report Enabled with Tables and Figures @ https://www.marketresearchfuture.com/reports/biopsy-devices-market-2250
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: salesteam@marketresearchfuture.com
